Application
Western blot analysis of RASGRF1-pS929 in MDA-MB231 cell line lysates (35ug/lane). RASGRF1 (arrow) was detected using the purified Pab.Application
Formalin-fixed and paraffin-embedded human brain tissue reacted with RASGRF1 Antibody (S929) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Product Name | RASGRF1 Antibody (S929) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:50~100 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | CDC25, GNRP, GRF1 |
|---|---|
| Alternative Names | RASGRF1 CDC25 GNRP GRF1 Ras-specific guanine nucleotide-releasing factor 1 Guanine nucleotide-releasing protein Ras-specific nucleotide exchange factor CDC25 |
| Molecular Weight(MW) | 145383 Da |
| Function | Promotes the exchange of Ras-bound GDP by GTP. |
| Tissue Specificity | This RASGRF1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide corresponding to amino acid residues surrounding S929 of human RASGRF1. |
| Entrez Gene | 5923 |
|---|
Application
Western blot analysis of RASGRF1-pS929 in MDA-MB231 cell line lysates (35ug/lane). RASGRF1 (arrow) was detected using the purified Pab.
Application
Formalin-fixed and paraffin-embedded human brain tissue reacted with RASGRF1 Antibody (S929) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Application Notes | WB:1:50~100 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
